Ambrx Biopharma Inc. (AMAM) Social Stream
AMBRX BIOPHARMA INC (AMAM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AMBRX BIOPHARMA INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-09 | 2 | $28 | $28 | $28 | $27.55 | 1.63% |
| 2022-03-22 | 2 | $26 | $26 | $26 | $27.55 | -5.63% |
| 2022-04-07 | 3 | $26 | $16 | $21 | $27.55 | -23.77% |
| 2022-05-06 | 4 | $21 | $16 | $18.5 | $27.55 | -32.85% |
| 2022-05-24 | 4 | $21 | $4 | $13.666 | $27.55 | -50.4% |
| 2022-09-17 | 4 | $16 | $4 | $9.333 | $27.55 | -66.12% |
| 2022-09-21 | 4 | $8 | $4 | $6.666 | $27.55 | -75.8% |
| 2022-11-16 | 4 | $8 | $4 | $5.333 | $27.55 | -80.64% |
| 2022-11-17 | 4 | $4 | $0.5 | $2.833 | $27.55 | -89.72% |
| 2023-02-28 | 4 | $6 | $0.5 | $3.5 | $27.55 | -87.3% |
| 2023-03-03 | 4 | $11 | $0.5 | $5.833 | $27.55 | -78.83% |
| 2023-04-05 | 4 | $12 | $0.5 | $6.166 | $27.55 | -77.62% |
| 2023-05-19 | 5 | $25 | $0.5 | $10.875 | $27.55 | -60.53% |
| 2023-06-02 | 6 | $30 | $0.5 | $14.7 | $27.55 | -46.64% |
| 2023-06-14 | 6 | $30 | $0.5 | $16.583 | $27.55 | -39.81% |
| 2023-07-07 | 5 | $30 | $0.5 | $16.583 | $27.55 | -39.81% |
| 2023-08-10 | 7 | $30 | $0.5 | $18.357 | $27.55 | -33.37% |
| 2023-09-12 | 8 | $30 | $0.5 | $19.312 | $27.55 | -29.9% |
| 2023-09-21 | 9 | $30 | $0.5 | $19.812 | $27.55 | -28.09% |
| 2023-09-25 | 9 | $30 | $0.5 | $19.277 | $27.55 | -30.03% |
| 2023-10-23 | 9 | $33 | $0.5 | $19.722 | $27.55 | -28.41% |
| 2023-11-13 | 7 | $33 | $10 | $23.333 | $27.55 | -15.31% |
| 2023-11-14 | 7 | $32 | $10 | $23.166 | $27.55 | -15.91% |
| 2023-11-15 | 8 | $32 | $9 | $23 | $27.55 | -16.52% |
| 2023-11-17 | 8 | $32 | $9 | $22.857 | $27.55 | -17.03% |
The Trend in the Analyst Price Target
AMAM's average price target has moved up $16.69 over the prior 32 weeks.
Over the past 38 weeks, AMAM's average upside potential has been 73.88%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-28 | 4 | 6 | 0.5 | 3.500 | 6.43 | -45.57% |
| 2023-07-07 | 5 | 30 | 0.5 | 16.583 | 15.15 | 9.46% |
| 2023-07-31 | 6 | 30 | 0.5 | 18.357 | 15.25 | 20.37% |
| 2023-09-25 | 9 | 30 | 0.5 | 19.277 | 10.74 | 79.49% |
| 2023-11-17 | 7 | 32 | 9.0 | 22.857 | 9.83 | 132.52% |
AMAM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 6 | 1 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 39 weeks, AMAM's average broker recommendation rating improved by 0.82.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, AMBRX BIOPHARMA INC's upside potential (average analyst target price relative to current price) is higher than 186.06% of them.
- AMAM has a lower variance in analysts' estimates than -2892.01% of all US stocks.
- AMAM has a higher number of analysts covering the stock than 2126.88% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Healthcare stocks, AMBRX BIOPHARMA INC's average analyst price target is higher than 1008.09% of them.
In the Pharmaceutical Products industry, ICVX, OMGA, and INKT are the three stocks most similar to AMBRX BIOPHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is AMAM a Buy, Hold or Sell? See the POWR Ratings now!